HEADER APOPTOSIS/INHIBITOR 07-FEB-14 4OQ5 TITLE CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-(4- TITLE 2 METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL)SULFONYL]AMINO}BENZOIC TITLE 3 ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A, B, C, D, E, F; COMPND 5 FRAGMENT: UNP RESIDUES 174-326; COMPND 6 SYNONYM: BCL-2-LIKE PROTEIN 3, BCL2-L-3, BCL-2-RELATED PROTEIN COMPND 7 EAT/MCL1, MCL1/EAT; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS APOPTOSIS-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.M.PETROS,S.L.SWANN,D.SONG,K.SWINGER,C.PARK,H.ZHANG,M.D.WENDT, AUTHOR 2 A.R.KUNZER,A.J.SOUERS,C.SUN REVDAT 2 28-FEB-24 4OQ5 1 REMARK SEQADV REVDAT 1 12-MAR-14 4OQ5 0 JRNL AUTH A.M.PETROS,S.L.SWANN,D.SONG,K.SWINGER,C.PARK,H.ZHANG, JRNL AUTH 2 M.D.WENDT,A.R.KUNZER,A.J.SOUERS,C.SUN JRNL TITL FRAGMENT-BASED DISCOVERY OF POTENT INHIBITORS OF THE JRNL TITL 2 ANTI-APOPTOTIC MCL-1 PROTEIN. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 1484 2014 JRNL REFN ISSN 0960-894X JRNL PMID 24582986 JRNL DOI 10.1016/J.BMCL.2014.02.010 REMARK 2 REMARK 2 RESOLUTION. 2.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 26737 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1340 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.21 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2601 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2187 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2478 REMARK 3 BIN R VALUE (WORKING SET) : 0.2170 REMARK 3 BIN FREE R VALUE : 0.2536 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.73 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 123 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7240 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 222 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 73.89 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.63980 REMARK 3 B22 (A**2) : 2.98960 REMARK 3 B33 (A**2) : 2.65010 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.31050 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.348 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.354 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7728 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10480 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2768 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 180 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1264 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7728 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 946 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 9646 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.27 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OQ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1000084810. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26737 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.855 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M MES, 30% REMARK 280 W/V PEG5000 MME, PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.87500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 164 REMARK 465 THR A 165 REMARK 465 LEU A 166 REMARK 465 VAL A 167 REMARK 465 PRO A 168 REMARK 465 ARG A 169 REMARK 465 GLY A 170 REMARK 465 SER A 171 REMARK 465 ILE A 264 REMARK 465 ASP A 323 REMARK 465 LEU A 324 REMARK 465 GLU A 325 REMARK 465 GLY A 326 REMARK 465 GLY B 164 REMARK 465 THR B 165 REMARK 465 LEU B 166 REMARK 465 VAL B 167 REMARK 465 PRO B 168 REMARK 465 ARG B 169 REMARK 465 GLY B 170 REMARK 465 SER B 171 REMARK 465 ASP B 323 REMARK 465 LEU B 324 REMARK 465 GLU B 325 REMARK 465 GLY B 326 REMARK 465 GLY C 164 REMARK 465 THR C 165 REMARK 465 LEU C 166 REMARK 465 VAL C 167 REMARK 465 PRO C 168 REMARK 465 ARG C 169 REMARK 465 GLY C 170 REMARK 465 SER C 171 REMARK 465 VAL C 321 REMARK 465 GLU C 322 REMARK 465 ASP C 323 REMARK 465 LEU C 324 REMARK 465 GLU C 325 REMARK 465 GLY C 326 REMARK 465 GLY D 164 REMARK 465 THR D 165 REMARK 465 LEU D 166 REMARK 465 VAL D 167 REMARK 465 PRO D 168 REMARK 465 ARG D 169 REMARK 465 GLY D 170 REMARK 465 SER D 171 REMARK 465 VAL D 321 REMARK 465 GLU D 322 REMARK 465 ASP D 323 REMARK 465 LEU D 324 REMARK 465 GLU D 325 REMARK 465 GLY D 326 REMARK 465 GLY E 164 REMARK 465 THR E 165 REMARK 465 LEU E 166 REMARK 465 VAL E 167 REMARK 465 PRO E 168 REMARK 465 ARG E 169 REMARK 465 GLY E 170 REMARK 465 SER E 171 REMARK 465 ASP E 323 REMARK 465 LEU E 324 REMARK 465 GLU E 325 REMARK 465 GLY E 326 REMARK 465 GLY F 164 REMARK 465 THR F 165 REMARK 465 LEU F 166 REMARK 465 VAL F 167 REMARK 465 PRO F 168 REMARK 465 ARG F 169 REMARK 465 GLY F 170 REMARK 465 SER F 171 REMARK 465 VAL F 321 REMARK 465 GLU F 322 REMARK 465 ASP F 323 REMARK 465 LEU F 324 REMARK 465 GLU F 325 REMARK 465 GLY F 326 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 197 -92.34 -145.15 REMARK 500 ARG A 201 86.85 55.39 REMARK 500 SER A 255 -124.23 -83.91 REMARK 500 ASP A 256 -57.40 59.47 REMARK 500 VAL A 321 -105.76 -106.46 REMARK 500 LYS B 197 -92.23 -144.98 REMARK 500 ARG B 201 86.75 55.31 REMARK 500 SER B 255 -125.33 -84.99 REMARK 500 ASP B 256 -62.40 60.53 REMARK 500 VAL B 321 -93.49 -121.20 REMARK 500 LYS C 197 -92.75 -145.23 REMARK 500 SER C 202 70.04 53.40 REMARK 500 ASP C 256 107.47 71.73 REMARK 500 LYS D 197 -92.95 -145.38 REMARK 500 ARG D 201 -132.59 77.97 REMARK 500 SER D 255 -127.23 -84.95 REMARK 500 ASP D 256 -60.29 58.56 REMARK 500 LYS E 197 -93.68 -145.83 REMARK 500 ARG E 201 85.05 55.42 REMARK 500 SER E 202 70.10 53.96 REMARK 500 SER E 255 -123.18 -84.89 REMARK 500 ASP E 256 96.24 29.19 REMARK 500 PHE E 319 62.00 -105.71 REMARK 500 VAL E 321 -124.44 -95.83 REMARK 500 LYS F 197 -92.59 -145.36 REMARK 500 ARG F 201 85.93 54.81 REMARK 500 SER F 202 70.35 53.25 REMARK 500 SER F 255 -124.91 -84.70 REMARK 500 ASP F 256 97.67 24.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU C 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU D 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU E 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2UU F 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OQ6 RELATED DB: PDB REMARK 900 HUMAN MCL-1 BOUND TO INHIBITOR 36 DBREF 4OQ5 A 174 326 UNP Q07820 MCL1_HUMAN 174 326 DBREF 4OQ5 B 174 326 UNP Q07820 MCL1_HUMAN 174 326 DBREF 4OQ5 C 174 326 UNP Q07820 MCL1_HUMAN 174 326 DBREF 4OQ5 D 174 326 UNP Q07820 MCL1_HUMAN 174 326 DBREF 4OQ5 E 174 326 UNP Q07820 MCL1_HUMAN 174 326 DBREF 4OQ5 F 174 326 UNP Q07820 MCL1_HUMAN 174 326 SEQADV 4OQ5 GLY A 164 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 THR A 165 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 LEU A 166 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 VAL A 167 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 PRO A 168 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ARG A 169 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY A 170 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 SER A 171 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 MET A 172 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ASP A 173 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY B 164 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 THR B 165 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 LEU B 166 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 VAL B 167 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 PRO B 168 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ARG B 169 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY B 170 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 SER B 171 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 MET B 172 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ASP B 173 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY C 164 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 THR C 165 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 LEU C 166 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 VAL C 167 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 PRO C 168 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ARG C 169 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY C 170 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 SER C 171 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 MET C 172 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ASP C 173 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY D 164 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 THR D 165 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 LEU D 166 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 VAL D 167 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 PRO D 168 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ARG D 169 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY D 170 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 SER D 171 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 MET D 172 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ASP D 173 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY E 164 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 THR E 165 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 LEU E 166 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 VAL E 167 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 PRO E 168 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ARG E 169 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY E 170 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 SER E 171 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 MET E 172 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ASP E 173 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY F 164 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 THR F 165 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 LEU F 166 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 VAL F 167 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 PRO F 168 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ARG F 169 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 GLY F 170 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 SER F 171 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 MET F 172 UNP Q07820 EXPRESSION TAG SEQADV 4OQ5 ASP F 173 UNP Q07820 EXPRESSION TAG SEQRES 1 A 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG SEQRES 2 A 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN SEQRES 3 A 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER SEQRES 4 A 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG SEQRES 5 A 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE SEQRES 6 A 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP SEQRES 7 A 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SEQRES 8 A 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU SEQRES 9 A 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR SEQRES 10 A 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER SEQRES 11 A 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU SEQRES 12 A 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE SEQRES 13 A 163 HIS VAL GLU ASP LEU GLU GLY SEQRES 1 B 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG SEQRES 2 B 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN SEQRES 3 B 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER SEQRES 4 B 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG SEQRES 5 B 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE SEQRES 6 B 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP SEQRES 7 B 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SEQRES 8 B 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU SEQRES 9 B 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR SEQRES 10 B 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER SEQRES 11 B 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU SEQRES 12 B 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE SEQRES 13 B 163 HIS VAL GLU ASP LEU GLU GLY SEQRES 1 C 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG SEQRES 2 C 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN SEQRES 3 C 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER SEQRES 4 C 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG SEQRES 5 C 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE SEQRES 6 C 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP SEQRES 7 C 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SEQRES 8 C 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU SEQRES 9 C 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR SEQRES 10 C 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER SEQRES 11 C 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU SEQRES 12 C 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE SEQRES 13 C 163 HIS VAL GLU ASP LEU GLU GLY SEQRES 1 D 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG SEQRES 2 D 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN SEQRES 3 D 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER SEQRES 4 D 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG SEQRES 5 D 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE SEQRES 6 D 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP SEQRES 7 D 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SEQRES 8 D 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU SEQRES 9 D 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR SEQRES 10 D 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER SEQRES 11 D 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU SEQRES 12 D 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE SEQRES 13 D 163 HIS VAL GLU ASP LEU GLU GLY SEQRES 1 E 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG SEQRES 2 E 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN SEQRES 3 E 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER SEQRES 4 E 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG SEQRES 5 E 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE SEQRES 6 E 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP SEQRES 7 E 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SEQRES 8 E 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU SEQRES 9 E 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR SEQRES 10 E 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER SEQRES 11 E 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU SEQRES 12 E 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE SEQRES 13 E 163 HIS VAL GLU ASP LEU GLU GLY SEQRES 1 F 163 GLY THR LEU VAL PRO ARG GLY SER MET ASP LEU TYR ARG SEQRES 2 F 163 GLN SER LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN SEQRES 3 F 163 ALA THR GLY ALA LYS ASP THR LYS PRO MET GLY ARG SER SEQRES 4 F 163 GLY ALA THR SER ARG LYS ALA LEU GLU THR LEU ARG ARG SEQRES 5 F 163 VAL GLY ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE SEQRES 6 F 163 GLN GLY MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP SEQRES 7 F 163 ASP VAL LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SEQRES 8 F 163 SER ASP GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU SEQRES 9 F 163 ILE SER PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR SEQRES 10 F 163 ILE ASN GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER SEQRES 11 F 163 ILE THR ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU SEQRES 12 F 163 VAL LYS GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE SEQRES 13 F 163 HIS VAL GLU ASP LEU GLU GLY HET 2UU A 401 57 HET 2UU B 401 57 HET 2UU C 401 57 HET 2UU D 401 57 HET 2UU E 401 57 HET 2UU F 401 57 HETNAM 2UU 4-(4-METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL) HETNAM 2 2UU SULFONYL]AMINO}BENZOIC ACID FORMUL 7 2UU 6(C30 H23 N O5 S) FORMUL 13 HOH *154(H2 O) HELIX 1 1 MET A 172 GLY A 192 1 21 HELIX 2 2 SER A 202 HIS A 224 1 23 HELIX 3 3 HIS A 224 ASP A 236 1 13 HELIX 4 4 ASN A 239 SER A 255 1 17 HELIX 5 5 GLY A 262 ARG A 263 5 2 HELIX 6 6 VAL A 265 VAL A 265 5 1 HELIX 7 7 THR A 266 ILE A 281 1 16 HELIX 8 8 GLN A 283 SER A 285 5 3 HELIX 9 9 CYS A 286 GLN A 309 1 24 HELIX 10 10 ARG A 310 HIS A 320 1 11 HELIX 11 11 ASP B 173 GLY B 192 1 20 HELIX 12 12 SER B 202 HIS B 224 1 23 HELIX 13 13 HIS B 224 ASP B 236 1 13 HELIX 14 14 ASN B 239 SER B 245 1 7 HELIX 15 15 SER B 245 SER B 255 1 11 HELIX 16 16 ASN B 260 ILE B 281 1 22 HELIX 17 17 GLN B 283 SER B 285 5 3 HELIX 18 18 CYS B 286 GLN B 309 1 24 HELIX 19 19 ARG B 310 HIS B 320 1 11 HELIX 20 20 ASP C 173 GLY C 192 1 20 HELIX 21 21 SER C 202 HIS C 224 1 23 HELIX 22 22 HIS C 224 ASP C 236 1 13 HELIX 23 23 ASN C 239 SER C 255 1 17 HELIX 24 24 ASN C 260 ILE C 281 1 22 HELIX 25 25 GLN C 283 SER C 285 5 3 HELIX 26 26 CYS C 286 GLN C 309 1 24 HELIX 27 27 ARG C 310 HIS C 320 1 11 HELIX 28 28 ASP D 173 GLY D 192 1 20 HELIX 29 29 SER D 202 HIS D 224 1 23 HELIX 30 30 HIS D 224 ASP D 236 1 13 HELIX 31 31 ASN D 239 SER D 255 1 17 HELIX 32 32 ASN D 260 ILE D 281 1 22 HELIX 33 33 GLN D 283 SER D 285 5 3 HELIX 34 34 CYS D 286 GLN D 309 1 24 HELIX 35 35 ARG D 310 PHE D 319 1 10 HELIX 36 36 ASP E 173 GLY E 192 1 20 HELIX 37 37 SER E 202 HIS E 224 1 23 HELIX 38 38 HIS E 224 ASP E 236 1 13 HELIX 39 39 ASN E 239 SER E 255 1 17 HELIX 40 40 ASN E 260 ILE E 281 1 22 HELIX 41 41 GLN E 283 SER E 285 5 3 HELIX 42 42 CYS E 286 GLN E 309 1 24 HELIX 43 43 ARG E 310 PHE E 319 1 10 HELIX 44 44 ASP F 173 GLY F 192 1 20 HELIX 45 45 SER F 202 HIS F 224 1 23 HELIX 46 46 HIS F 224 ASP F 236 1 13 HELIX 47 47 ASN F 239 SER F 255 1 17 HELIX 48 48 ASN F 260 ILE F 281 1 22 HELIX 49 49 GLN F 283 SER F 285 5 3 HELIX 50 50 CYS F 286 GLN F 309 1 24 HELIX 51 51 ARG F 310 PHE F 319 1 10 SITE 1 AC1 14 PHE A 228 MET A 231 LEU A 235 MET A 250 SITE 2 AC1 14 VAL A 253 ARG A 263 THR A 266 LEU A 267 SITE 3 AC1 14 PHE A 270 ALA F 227 GLY F 230 MET F 231 SITE 4 AC1 14 LYS F 234 2UU F 401 SITE 1 AC2 13 PHE B 228 MET B 231 LEU B 235 ARG B 263 SITE 2 AC2 13 THR B 266 LEU B 267 PHE B 270 GLY B 271 SITE 3 AC2 13 ALA E 227 GLY E 230 LYS E 234 2UU E 401 SITE 4 AC2 13 HOH E 527 SITE 1 AC3 15 PHE C 228 MET C 231 LEU C 235 VAL C 253 SITE 2 AC3 15 PHE C 254 ARG C 263 THR C 266 LEU C 267 SITE 3 AC3 15 PHE C 270 LEU C 290 THR D 226 ALA D 227 SITE 4 AC3 15 GLY D 230 MET D 231 LYS D 234 SITE 1 AC4 14 THR C 226 ALA C 227 LYS C 234 PHE D 228 SITE 2 AC4 14 MET D 231 LEU D 235 MET D 250 VAL D 253 SITE 3 AC4 14 PHE D 254 ARG D 263 THR D 266 LEU D 267 SITE 4 AC4 14 PHE D 270 LEU D 290 SITE 1 AC5 16 THR B 226 ALA B 227 MET B 231 2UU B 401 SITE 2 AC5 16 PHE E 228 MET E 231 LYS E 234 LEU E 235 SITE 3 AC5 16 MET E 250 VAL E 253 PHE E 254 ARG E 263 SITE 4 AC5 16 THR E 266 LEU E 267 PHE E 270 LEU E 290 SITE 1 AC6 14 THR A 226 ALA A 227 MET A 231 2UU A 401 SITE 2 AC6 14 HOH A 517 MET F 231 LEU F 235 MET F 250 SITE 3 AC6 14 VAL F 253 PHE F 254 ARG F 263 THR F 266 SITE 4 AC6 14 LEU F 267 PHE F 270 CRYST1 71.112 109.750 76.544 90.00 93.31 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014062 0.000000 0.000813 0.00000 SCALE2 0.000000 0.009112 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013086 0.00000